Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

31
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

849
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
849
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

51
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
51
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

657
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
657
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

71
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
71

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comprehensive Survey of Deep Learning Approaches in Image Processing.

Sensors (Basel, Switzerland)·2025
Same author

A Comprehensive Survey of Machine Learning Techniques and Models for Object Detection.

Sensors (Basel, Switzerland)·2025
Same author

Efficient Data-Driven Machine Learning Models for Cardiovascular Diseases Risk Prediction.

Sensors (Basel, Switzerland)·2023
Same author

Long-Term Coronary Artery Disease Risk Prediction with Machine Learning Models.

Sensors (Basel, Switzerland)·2023
Same author

Supervised Machine Learning Models to Identify Early-Stage Symptoms of SARS-CoV-2.

Sensors (Basel, Switzerland)·2023
Same author

An Efficient Distributed Approach for Cooperative Spectrum Sensing in Varying Interests Cognitive Radio Networks.

Sensors (Basel, Switzerland)·2022

Related Experiment Video

Updated: Sep 3, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Machine Learning Methods for Hypercholesterolemia Long-Term Risk Prediction.

Elias Dritsas1, Maria Trigka1

  • 1Department of Computer Engineering and Informatics, University of Patras, 26504 Patras, Greece.

Sensors (Basel, Switzerland)
|July 27, 2022
PubMed
Summary

Machine learning models can predict high cholesterol (hypercholesterolemia) risk. Soft Voting with Rotation and Random Forest achieved high accuracy, aiding early detection and prevention of heart disease.

Keywords:
cholesteroldata analysishypercholesterolemialong-term predictionmachine learning

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

38.3K

Related Experiment Videos

Last Updated: Sep 3, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

38.3K

Area of Science:

  • Cardiology
  • Biomedical Informatics
  • Data Science

Background:

  • High cholesterol (hypercholesterolemia) poses significant risks to heart health by blocking blood vessels and impeding circulation.
  • Machine learning (ML) offers powerful tools for risk prediction in healthcare, assisting medical professionals.
  • Early and accurate prediction of hypercholesterolemia is crucial for preventing severe cardiovascular events.

Purpose of the Study:

  • To develop efficient machine learning (ML) risk prediction tools for hypercholesterolemia.
  • To identify key features associated with hypercholesterolemia through data analysis.
  • To evaluate and compare the performance of various ML models for hypercholesterolemia risk prediction.

Main Methods:

  • A supervised machine learning (ML) methodology was employed.
  • Data understanding analysis was performed to explore feature importance for hypercholesterolemia.
  • Multiple ML models were trained and tested, with performance evaluated using precision, recall, accuracy, F-measure, and AUC metrics.

Main Results:

  • Soft Voting with Rotation and Random Forest models demonstrated superior performance.
  • These models achieved an AUC of 94.5%, precision of 92%, recall of 91.8%, and F-measure of 91.7%.
  • An overall accuracy of 91.75% was recorded for the best-performing models.

Conclusions:

  • The developed ML models, particularly Soft Voting with Rotation and Random Forest, are highly effective for hypercholesterolemia risk prediction.
  • These findings can support healthcare providers in proactive patient management and cardiovascular disease prevention.
  • The study underscores the potential of ML in enhancing diagnostic accuracy and risk stratification for hypercholesterolemia.